| Clostridium Difficile Infection |
1 |
1 |
| Fecal Transplant |
0 |
0.99 |
| Microbiome |
0 |
0.98 |
| Biologic Therapy |
0 |
0.96 |
| Clinical Guidelines |
0 |
0.5 |
| Antibiotics |
0 |
0.46 |
| Irritable Bowel Syndrome |
0 |
0.97 |
| Inflammatory Bowel Disease |
0 |
0.96 |
| Transplantation |
0 |
0.38 |
| Prophylaxis |
0 |
0.19 |
| Clinical Research |
0 |
0.13 |
| North Carolina |
0 |
0.13 |
| Healthcare and Medical Technology |
0 |
0.08 |
| Ulcerative Colitis |
0 |
0.08 |
| Crohn Disease |
0 |
0.07 |
| Diarrhea |
0 |
0.07 |
| Allergy |
0 |
0.06 |
| Clostridial Infection |
0 |
0.06 |
| Colitis |
0 |
0.06 |
| Fellowship |
0 |
0.06 |
| Gastrointestinal Disease |
0 |
0.06 |
| Grant |
0 |
0.06 |
| Ileus |
0 |
0.06 |
| Immunocompromise |
0 |
0.06 |
| Kidney |
0 |
0.06 |
| Pouchitis |
0 |
0.06 |
| Refractory |
0 |
0.06 |
| Shock |
0 |
0.06 |
| White Blood Cell Count |
0 |
0.06 |